Improved efficacy of appetite suppression by lipoic acid particles prepared by nanocomminution lipoic acid particles

Drug Development and Industrial Pharmacy

Volumn 35, Issue 11, 2009, Pages 1305-1311

  Park, Chul Ho ^a   Youn, Hye Ri ^a   Lee, Jonghwi ^a   Lee, Ki Up ^b   Park, Joong Yeol ^b   Koh, Eun Hee ^b   Kim, Hyoun Sik ^b  

^a Chung Ang University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Appetite suppression; Comminution; Lipoic acid; Nanoparticles; Self polymerization

Indexed keywords

DISULFIDE; NANOPARTICLE; POLY[3 (BUTANE CARBOXLIC ACID)PROPYL]DISULFIDE; THIOCTIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; FOOD INTAKE; MALE; MOUSE; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; POLYMERIZATION;

ANIMALS; APPETITE DEPRESSANTS; DRUG COMPOUNDING; EATING; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; PARTICLE SIZE; POLYMERS; SOLUBILITY; THIOCTIC ACID;

EID: 70350282927     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040902902385     Document Type: Article

References (27)

1. Fujiwara K, Okamuraikeda K, Motokawa Y. (1995). Assay for protein lipoylation reaction. Biothiols Pt A, 251:340-347
2. Booker SJ. (2004). Unraveling the pathway of lipoic acid biosynthesis. Chem Biol, 11(1):10-12
3. Cicchillo RM, Booker SJ. (2005). Mechanistic investigations of lipoic acid biosynthesis in Escherichia coli: Both sulfur atoms in lipoic acid are contributed by the same lipoyl synthase polypeptide. J Am Chem Soc, 127(9):2860-2861
4. Bilska A, Wlodek L. (2005). Lipoic acid-the drug of the future? Pharmacol Rep, 57(5):570-577
5. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, et al. (2004). Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med, 10(7):727-733
6. Packer L, Tritschler HJ, Wessel K. (1997). Neuroprotection by the metabolic antioxidant α-lipoic acid. Free Radic Biol Med, 22(1-2):359-378
7. Strodter D, Lehmann E, Lehmann U, Tritschler HJ, Bretzel RG, Federlin K. (1995). The influence of thioctic acid on metabolism and function of the diabetic heart. Diabetes Res Clin Pract, 29(1): 19-26.
8. Breithaupt-Grogler K, Niebch G, Schneider E, Erb K, Hermann R, BlumeHH, etal. (1999). Dose-proportionalityoforalthioctic acid-coincidence of assessments via pooled plasma and individual data. Eur J Pharm Sci, 8(1):57-65.
9. Barltrop JA, Hayes PM, Calvin M. (1954). The chemistry of 1,2-dithiolane (trimethylene disulfide) as a model for the primary quantum conversion act in photosynthesis. J Am Chem Soc, 76(17):4348-4367
10. Park CH, Kim AR, Yun HL, Lee J. (2006). Ring opening and polymerization of alpha-lipoic acid. Polymer-Korea, 30(4): 357-361
11. Thomas RC, Reed LJ. (1956). Disulfide polymers of DL-lipoic acid. J Am Chem Soc, 78(23):6148-6149
12. Fava A, Reichenbach G, Peron U. (1967). Kinetics of the thiol-disulfide exchange. II. Oxygen-promoted free-radical exchange between aromatic thiols and disulfides. J Am Chem Soc, 89(25):6696-6700
13. Weaver KH, Rabenstein DL. (1995). Thiol/disulfide exchange reactions of ovothiol A with glutathione. J Org Chem, 60(6): 1904-1907
14. Pax H, Blume A. (1993). Polymerizable phospholipids with lipoic acid as head group: Synthesis and phase properties. Chem Phys Lipids, 66(1-2):63-74.
15. Stefely J, Markowitz MA, Regen SL. (1988). Permeability characteristics of lipid bilayers from lipoic acid-derived phosphati-dylcholines. Comparison of monomeric, crosslinked and noncrosslinked polymerized membranes. J Am Chem Soc, 110(22):7463-7469
16. Saito G, Swanson JA, Lee K-D. (2003). Drug delivery strategy utilizing conjugation via reversible disulfide linkages: Role and site of cellular reducing activities. Adv Drug Deliv Rev, 55(2): 199-215.
17. Reed LJ, DeBusk BG, Hornberger CS, Gunsalus IC. (1953). Interrelationships of lipoic acids. J Am Chem Soc, 75(6):1271-1273
18. Singh R, Whitesides GM. (1990). Degenerate intermolecular thiolate-disulfide interchange involving cyclic five-membered disulfides is faster by apprx. 103 than that involving six- or seven-membered disulfides. J Am Chem Soc, 112(17):6304-6309
19. Blaschke G, Scheidemantel U, Bethge H, Moller R, Beisswenger T, Huthmacher K. (1999). Preparation and use of salts of the pure enantiomers of α-lipoic acid. US patent 5281722.
20. Gruzman A, Hidmi A, Katzhendler J, Haj-Yehie A, Sasson S. (2004). Synthesis and characterization of new and potent α-lipoic acid derivatives. Bioorg Med Chem, 12(5):1183-1190
21. Hettche H, Rischer M, Sarlikiotis W. (1999). Dosage forms containing thiotic acid or solid salts of thioctic acid with improved release and bioavailability. US patent 5990152.
22. Marangon K, Devaraj S, Tirosh O, Packer L, Jialal I. (1999). Comparison of the effect of alpha-lipoic acid and alpha-tocopherol supplementation on measures of oxidative stress. Free Radic Biol Med, 27(9-10):1114-1121
23. Merisko-Liversidge E, Liversidge GG, Cooper ER. (2003). Nano-sizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 18(2):113-120
24. Noyes AA, Whitney WR. (1897). The rate of solid substances in their own solutions. J Am Chem Soc, 19:930-937
25. Keck CM, Müller RH. (2006). Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm, 62(1):3-16.
26. Liversidge GG, Cundy KC. (1995). Particle-size reduction for improvement of oral bioavailability of hydrophobic drugs: 1. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm, 125(1):91-97
27. Wu Y, Loper A, Landis E, Hettrick L, Novak L, Lynn K, et al. (2004). The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: A Beagle dog model predicts improved bioavailability and diminished food effect on absorption inhuman. Int J Pharm, 285(1-2): 135-146